MDC1 and osteosarcoma: To this end, we used a human osteosarcoma cell line U2OS stably expressing GFP-tagged MDC1 and RFP-H2B in which the endogenous MDC1 was knocked out using CRISPR/Cas9 (Leimbacher et al., 2019).